Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18700,152,0.97 [0.84-1.13],0.7265117445146784
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19669,205,0.99 [0.87-1.12],0.8241593403961502
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19438,1424,1.02 [0.97-1.07],0.3953960409075669
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,19684,459,0.99 [0.91-1.08],0.7608399540313839
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19033,3488,1.01 [0.98-1.04],0.5674558386557578
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19013,3532,0.99 [0.96-1.02],0.5545630882429993
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19438,1164,1.01 [0.96-1.07],0.5915043039947527
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19598,111,0.92 [0.77-1.09],0.3405822566100858
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17358,1036,0.99 [0.93-1.05],0.7153018296142685
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16731,1256,0.99 [0.94-1.04],0.6419363498634534
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16379,276,1.02 [0.91-1.14],0.7123581711982008
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12832,2241,0.97 [0.94-1.01],0.1703337750182098
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16321,398,1.03 [0.94-1.13],0.5353658734943063
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19652,1378,1.01 [0.96-1.07],0.5959834852090331
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Mycoses,19754,529,0.98 [0.91-1.07],0.6812656474690775
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19018,1004,1.00 [0.94-1.06],0.8852478413158299
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19696,1148,0.98 [0.93-1.04],0.5559732961268053
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18479,205,0.99 [0.87-1.12],0.8559676171886892
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19804,51,0.97 [0.75-1.25],0.7952436520014655
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19548,1000,0.99 [0.93-1.05],0.707528434547648
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19550,63,1.10 [0.87-1.39],0.4116091186985953
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19747,113,1.06 [0.89-1.26],0.5279814554476303
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19732,98,1.07 [0.89-1.29],0.4550274910945527
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18403,389,1.09 [0.99-1.20],0.0676065276981762
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18268,254,1.00 [0.89-1.12],0.9871834968953572
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18377,103,1.17 [0.98-1.40],0.0898447356311723
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19789,46,0.88 [0.67-1.15],0.3422904310418059
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19743,151,0.99 [0.85-1.15],0.9039131284120612
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Viral warts,19641,49,1.27 [0.98-1.65],0.0674086685177873
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19662,70,0.83 [0.66-1.03],0.0965675211167881
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm,19554,224,0.94 [0.83-1.06],0.3312814203475917
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19729,36,0.93 [0.68-1.26],0.6419200224603959
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19715,41,0.93 [0.70-1.24],0.6240827877543298
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9355,71,0.91 [0.73-1.13],0.381968762850456
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19408,1407,0.96 [0.92-1.01],0.1385477407419376
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of meninges,19790,57,0.96 [0.75-1.22],0.7327554477314233
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19725,68,1.05 [0.84-1.31],0.6698334935448956
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19780,102,1.03 [0.86-1.23],0.7632744689882854
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm of ovary,10399,62,1.03 [0.82-1.30],0.8096023410729176
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,19770,380,0.95 [0.86-1.04],0.2677224620972777
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Caecum,19783,325,0.98 [0.88-1.08],0.6583360904485638
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19677,72,0.95 [0.77-1.19],0.6754904005353715
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,19768,216,0.97 [0.85-1.09],0.5866001860987295
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Rectum,19724,352,0.95 [0.86-1.05],0.3447550354841694
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19671,589,0.97 [0.90-1.05],0.4326812606482192
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,19761,447,0.97 [0.89-1.06],0.503879491082835
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Carcinoma in situ of breast,7824,45,0.87 [0.66-1.15],0.3295843622603666
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7857,56,1.10 [0.86-1.40],0.4636657838328245
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",14178,64,0.98 [0.78-1.23],0.8413353789641866
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",14196,82,0.86 [0.70-1.05],0.1374545052807294
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19753,109,0.90 [0.75-1.07],0.2231916371645934
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Haemangioma, any site",19754,106,0.89 [0.74-1.07],0.2044343877717564
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Leiomyoma of uterus,10166,144,1.01 [0.87-1.18],0.9016546336599756
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Lung cancer and mesothelioma,12623,428,0.94 [0.86-1.03],0.2101648682614828
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Lymphoid leukaemia,14179,65,0.98 [0.78-1.23],0.8602074014203984
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14303,189,1.12 [0.98-1.28],0.0908751546547987
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14373,259,0.99 [0.88-1.11],0.8195781271478699
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",7935,94,0.91 [0.75-1.10],0.3272078310900325
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14209,95,1.06 [0.88-1.28],0.5314726004640026
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14237,123,1.05 [0.89-1.24],0.5661782623574144
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14223,109,0.91 [0.76-1.09],0.2953177473047429
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",7921,80,0.90 [0.73-1.10],0.3028170088897118
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14222,108,0.97 [0.81-1.16],0.7713189453359259
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7092,819,0.94 [0.88-1.00],0.0561763586537008
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14229,115,0.86 [0.72-1.02],0.0867617794631076
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",14197,83,1.03 [0.84-1.26],0.7631820048740071
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14233,119,1.06 [0.89-1.25],0.5140514738274407
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Melanocytic naevi,19679,159,1.12 [0.97-1.30],0.1151104837795655
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Melanocytic naevi of trunk,19781,67,1.34 [1.08-1.67],0.0092940807453214
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Melanoma in situ,14160,99,1.06 [0.88-1.28],0.5315419159219577
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14217,103,0.91 [0.76-1.09],0.3059420385025331
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14282,168,0.92 [0.80-1.06],0.2510839511690254
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14410,296,0.84 [0.75-0.93],0.0014227237354284
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14222,108,0.94 [0.79-1.12],0.4851979069750638
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,Other benign neoplasms of skin,19659,145,0.98 [0.84-1.14],0.8133952584446588
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15360,1246,0.97 [0.92-1.02],0.1902516460506227
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15426,1312,0.98 [0.93-1.03],0.3942342092777762
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19542,326,0.95 [0.86-1.05],0.3297454782431757
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,17886,109,0.95 [0.80-1.14],0.6048495571702824
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19277,61,1.17 [0.93-1.48],0.1887356286813895
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19188,2904,1.01 [0.98-1.04],0.6098012188974031
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18397,60,1.29 [1.02-1.64],0.0303062728282356
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19411,60,0.90 [0.71-1.15],0.416420582328455
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19398,1621,1.00 [0.96-1.05],0.8374828246291517
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19396,1619,1.00 [0.96-1.05],0.8714337368642069
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,17873,96,0.86 [0.71-1.04],0.1090368376367688
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19503,1166,1.11 [1.05-1.17],0.0001676298516411
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19451,100,1.03 [0.85-1.24],0.773397799952886
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19276,60,0.79 [0.62-1.00],0.0535230061562961
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19287,71,1.03 [0.83-1.28],0.7932382036922324
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19647,296,0.82 [0.74-0.92],0.0004614609195378
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19700,33,0.85 [0.62-1.18],0.3339325164808093
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19592,241,0.74 [0.66-0.84],1.2581984100340198e-06
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18449,112,1.04 [0.88-1.24],0.6433536310525871
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13398,332,0.97 [0.88-1.08],0.6153109010218372
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18529,85,1.00 [0.80-1.23],0.9638254264692168
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18538,94,1.05 [0.86-1.27],0.6440503044515073
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,13129,63,1.07 [0.85-1.35],0.5740773764503504
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18440,44,0.94 [0.72-1.25],0.6841944150563857
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,17823,268,0.90 [0.80-1.00],0.06022970467519
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19161,757,0.93 [0.87-1.00],0.0402475849621073
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,18817,413,0.93 [0.84-1.01],0.0962131981456511
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18548,144,1.02 [0.88-1.19],0.7567398368314012
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19580,1184,1.06 [1.01-1.12],0.0249397887394878
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,16757,1154,1.07 [1.01-1.12],0.0227455977088569
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",13131,65,0.88 [0.70-1.11],0.2717956364197426
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",17900,86,1.09 [0.90-1.33],0.3907925412212842
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13369,303,0.98 [0.88-1.09],0.716462243425295
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,13113,47,1.06 [0.81-1.39],0.6720890796630443
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16926,3860,1.02 [0.99-1.05],0.2613046030829453
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13296,230,0.85 [0.76-0.97],0.0121645567530456
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13658,592,0.95 [0.88-1.03],0.202658563636059
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19756,307,0.98 [0.88-1.09],0.7342464665708541
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19574,125,0.84 [0.71-0.99],0.036528812905955
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,13190,124,0.95 [0.81-1.12],0.5625783945683862
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",13136,70,1.00 [0.80-1.24],0.9846115527023744
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19270,1456,0.99 [0.94-1.04],0.622162562606879
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13379,313,1.01 [0.91-1.12],0.8800622883558947
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13394,328,0.95 [0.85-1.05],0.287635378415733
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13785,719,1.07 [1.00-1.15],0.0575794308874373
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,13193,127,0.91 [0.77-1.07],0.2462509527151981
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19568,119,0.82 [0.69-0.98],0.0253959727065757
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,13821,755,0.99 [0.92-1.06],0.7114789234411449
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13615,549,0.94 [0.86-1.01],0.0954669213851285
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17616,61,1.05 [0.83-1.33],0.6915776537659477
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18491,5425,1.00 [0.97-1.02],0.7837627333762187
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,17863,49,0.94 [0.73-1.23],0.6619773181716859
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,17859,45,0.89 [0.68-1.17],0.4034173523796959
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19654,1563,0.97 [0.93-1.02],0.2418607115763648
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19652,1561,0.97 [0.93-1.02],0.2854344352502974
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,17868,54,0.88 [0.68-1.13],0.3022500527034836
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19505,970,1.03 [0.97-1.09],0.3398120325734211
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14922,1856,0.97 [0.93-1.02],0.2437478967706584
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19794,243,0.94 [0.83-1.05],0.2734119759458164
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18501,97,0.90 [0.75-1.09],0.2929701237282774
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18634,99,0.96 [0.80-1.15],0.6476110023707189
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,18678,143,1.16 [0.99-1.35],0.0620733557126571
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13227,161,0.97 [0.84-1.13],0.7095519224968145
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17441,158,1.03 [0.89-1.19],0.6894438727233339
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2114,81,1.09 [0.87-1.35],0.4536748489754212
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2251,250,0.99 [0.88-1.12],0.932585240516422
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17353,70,1.14 [0.91-1.43],0.2405330392825067
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2081,49,0.92 [0.69-1.23],0.5771304160698512
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19109,1826,1.01 [0.97-1.05],0.6521222834322269
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,18910,506,0.88 [0.81-0.96],0.0032949835948805
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,17922,367,0.97 [0.88-1.07],0.5801108587754892
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,13961,895,0.96 [0.90-1.02],0.1635333216127723
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19688,265,0.83 [0.74-0.93],0.0014345001599484
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18561,224,0.84 [0.74-0.95],0.0045096843872812
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Angina pectoris,17168,1296,1.00 [0.95-1.05],0.9716593169334083
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18650,313,0.84 [0.76-0.93],0.0009759763084957
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18405,68,0.95 [0.76-1.19],0.6483806827857803
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18569,232,1.00 [0.89-1.13],0.96104611509855
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,10102,2368,0.95 [0.92-0.99],0.0173760559244246
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,AV-block,15158,553,0.99 [0.91-1.07],0.7851402396940398
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19732,467,0.98 [0.90-1.07],0.633208800659953
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,7956,222,1.03 [0.91-1.16],0.6315095192159291
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14778,173,0.85 [0.74-0.98],0.0278907540724777
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14693,88,1.00 [0.82-1.21],0.9888696025730792
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19798,62,0.98 [0.77-1.24],0.8755128801459029
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Conduction disorders,15885,1280,1.00 [0.95-1.05],0.8743309504535536
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18169,2319,0.99 [0.95-1.03],0.5695838100703075
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,16042,7614,0.99 [0.97-1.01],0.2960478528082225
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18484,290,0.86 [0.77-0.96],0.0065314572332293
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Endocarditis,14683,78,1.01 [0.82-1.24],0.960874325026432
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19558,1372,1.01 [0.96-1.06],0.6500870140864917
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypertension,17089,6732,1.00 [0.98-1.02],0.970341320683892
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",17093,6736,1.00 [0.98-1.02],0.9963365812931134
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19662,85,0.77 [0.63-0.95],0.013545593445339
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10598,241,1.04 [0.92-1.18],0.4956019488815664
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10485,128,1.02 [0.87-1.21],0.7807630576926583
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Hypotension,19652,1316,1.01 [0.96-1.06],0.7485105458550045
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18719,123,0.82 [0.69-0.97],0.0181062194920459
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18324,2452,1.00 [0.96-1.04],0.9760480616756974
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19380,678,0.99 [0.92-1.06],0.7411639134075809
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,15028,423,1.01 [0.92-1.10],0.8762923560257072
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19249,891,1.01 [0.95-1.07],0.7479056042731541
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16639,767,1.04 [0.97-1.11],0.2615043028498102
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19692,165,1.18 [1.03-1.37],0.0197529330433553
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19765,340,1.00 [0.91-1.11],0.9512355396254724
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,18251,57,0.85 [0.66-1.10],0.2112919622557557
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other aneurysm,18423,86,1.07 [0.88-1.30],0.5041776732655581
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,15102,497,1.02 [0.94-1.11],0.5582166354497847
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18446,109,0.97 [0.82-1.16],0.7737622588664287
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18607,270,0.94 [0.84-1.05],0.290051163470035
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,14793,188,1.07 [0.94-1.22],0.3292714804722401
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,18281,87,1.03 [0.84-1.25],0.7875156262749119
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18229,35,1.03 [0.76-1.41],0.832302781908661
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18096,70,0.99 [0.79-1.24],0.9205062259262164
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18333,139,0.95 [0.81-1.12],0.5598651393392751
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15797,1192,0.97 [0.92-1.02],0.2530021167074337
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18387,51,0.87 [0.67-1.13],0.3036690939238786
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18942,605,0.94 [0.88-1.02],0.1357386481310015
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19155,467,1.01 [0.93-1.10],0.782216793301571
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",18833,807,0.96 [0.90-1.03],0.241568699732174
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,8076,342,0.97 [0.88-1.07],0.5831857238002567
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18795,490,0.97 [0.89-1.05],0.4797286847926441
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18558,364,0.87 [0.79-0.96],0.0040155828599711
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19191,503,0.96 [0.88-1.04],0.3007876684346636
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19714,806,0.97 [0.91-1.04],0.3797229173545304
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,15032,427,1.00 [0.91-1.09],0.9353155841749468
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19150,462,1.01 [0.93-1.10],0.79244264378913
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18242,216,0.91 [0.80-1.04],0.1567983305330386
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19364,768,0.97 [0.91-1.04],0.3623364124660392
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19351,799,0.98 [0.91-1.04],0.4604259215707819
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18691,49,0.97 [0.75-1.26],0.8044871488954635
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18420,83,0.84 [0.69-1.03],0.0880038727221454
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,18968,266,1.08 [0.97-1.21],0.1761635310776044
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18633,275,0.99 [0.89-1.11],0.914399729518224
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Varicose veins,18626,432,1.02 [0.93-1.11],0.6842809204946976
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18353,98,0.82 [0.68-0.99],0.0357215538383235
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19567,797,0.92 [0.87-0.99],0.0184115252848359
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19734,287,1.01 [0.90-1.12],0.9105499279076664
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17013,1178,1.04 [0.99-1.10],0.1579154663333412
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Any mental disorder,19368,3533,1.02 [0.98-1.05],0.3170568498156723
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19710,336,0.98 [0.89-1.09],0.7190161961249009
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17039,1204,1.07 [1.02-1.13],0.0109058485938997
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15897,62,0.98 [0.78-1.25],0.8989882653000458
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Smoking dependency,19365,983,1.04 [0.98-1.10],0.1665474830042137
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",17058,1223,1.03 [0.98-1.08],0.2850420487685958
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter V Mental and behavioural disorders,Vascular dementia,19090,196,0.90 [0.79-1.03],0.1312347335543431
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Alzheimer disease,19801,507,0.94 [0.86-1.02],0.1186290775522644
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",12336,96,1.02 [0.84-1.23],0.8616692355483508
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Bell's palsy,18260,71,0.88 [0.71-1.10],0.2766385824853898
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18610,421,1.07 [0.97-1.17],0.1601351534512634
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Cerebral cysts,19432,202,1.01 [0.89-1.16],0.8229240191259797
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19741,327,0.86 [0.78-0.96],0.0054793483857999
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19101,72,1.05 [0.84-1.30],0.6823481766184243
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19786,63,0.86 [0.68-1.09],0.2246131335726003
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19295,65,1.05 [0.84-1.32],0.6568956813989968
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Epilepsy,18557,249,0.96 [0.85-1.08],0.4848164124996079
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19419,1111,1.01 [0.96-1.07],0.6104963533024261
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19754,535,0.92 [0.85-1.00],0.0526279531687635
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19242,2832,0.95 [0.92-0.98],0.002759818752711
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,19493,45,1.15 [0.88-1.51],0.2989406988924115
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Hemiplegia,19683,269,0.90 [0.80-1.01],0.0685549316060559
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Hydrocephalus,19291,61,0.93 [0.73-1.17],0.5220262652608482
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19789,58,1.00 [0.78-1.27],0.9698581396587026
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18252,63,0.86 [0.68-1.08],0.1900406024411832
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18250,61,0.94 [0.74-1.19],0.6022048969822561
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Memory loss,18877,131,1.00 [0.85-1.17],0.9631902113874078
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Migraine,18540,232,1.02 [0.91-1.16],0.7023627795867795
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19761,212,1.03 [0.90-1.16],0.6854043006583082
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Motor neuron disease,12427,165,1.04 [0.90-1.20],0.6255091748301571
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19692,50,0.97 [0.75-1.25],0.8008648876864666
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19206,1017,1.01 [0.95-1.07],0.83060052865359
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Neurological diseases,18552,3512,0.99 [0.96-1.02],0.3953166164980557
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19273,244,0.95 [0.84-1.07],0.3714774843716474
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18519,330,1.03 [0.93-1.14],0.5436202754450559
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19733,283,1.04 [0.93-1.16],0.5310511943367748
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15021,809,0.96 [0.90-1.02],0.1675950678915807
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19298,68,0.86 [0.68-1.07],0.1723540566364322
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19359,129,0.86 [0.73-1.02],0.0781436553314505
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19398,179,0.94 [0.82-1.08],0.4103858397204277
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18267,78,0.91 [0.74-1.12],0.3818645248648193
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other headache syndromes,18355,47,1.07 [0.82-1.40],0.5983223041354238
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other neurological diseases,19706,476,0.99 [0.91-1.07],0.731767094940972
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Other sleep disorders,18725,417,0.99 [0.91-1.09],0.8518806061143812
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Parkinson's disease,19771,338,0.91 [0.83-1.01],0.0746553248792919
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19270,40,1.10 [0.82-1.46],0.5317171359853646
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,19800,81,0.94 [0.76-1.15],0.5477977558686578
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Sleep apnoea,19617,361,0.97 [0.88-1.08],0.6051413132887351
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19500,50,1.04 [0.81-1.35],0.7414264194464816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19789,185,1.01 [0.88-1.15],0.9116496045872728
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18250,61,1.08 [0.85-1.37],0.5174986628604515
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19801,512,0.94 [0.86-1.02],0.1162932649766504
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),19035,190,0.91 [0.79-1.04],0.1627788823899619
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19260,126,1.01 [0.86-1.18],0.9364324837981082
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19430,485,0.95 [0.87-1.03],0.1920159915997818
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19597,220,0.96 [0.84-1.09],0.5121272256657339
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,18747,56,1.01 [0.79-1.30],0.907220843791172
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18727,36,1.38 [1.02-1.88],0.0356834898800331
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19700,63,1.11 [0.88-1.40],0.3672293803399526
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19533,194,0.97 [0.85-1.10],0.6002962264086742
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2085,52,0.88 [0.67-1.16],0.3746683968814556
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2559,92,1.07 [0.88-1.31],0.4861795207195284
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19225,91,1.10 [0.90-1.33],0.3499470178066106
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19565,1204,1.03 [0.98-1.09],0.2677193579830029
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19442,751,0.99 [0.92-1.05],0.681477342202013
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18944,253,1.05 [0.94-1.18],0.4026300289024748
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19744,799,0.98 [0.91-1.04],0.4593231813746946
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19795,66,1.21 [0.97-1.52],0.0967290881072897
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19691,746,0.97 [0.90-1.03],0.313378906225248
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19766,427,1.01 [0.92-1.10],0.8781685555561559
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19696,188,1.04 [0.91-1.18],0.6044602160287975
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,18779,88,1.12 [0.92-1.36],0.2775887026689775
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,18780,89,0.96 [0.79-1.17],0.7076342854917222
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,18753,62,1.15 [0.91-1.46],0.2322449983326913
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19686,848,1.00 [0.93-1.06],0.884005949529423
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,19066,228,0.96 [0.85-1.08],0.4907480905031703
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,19005,60,0.84 [0.66-1.07],0.1624765924234948
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19446,107,1.00 [0.84-1.20],0.9726974013114577
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19671,332,0.98 [0.89-1.08],0.7052958856725653
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19125,180,0.99 [0.87-1.14],0.9089965431928098
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19625,117,1.01 [0.85-1.20],0.9054392837872852
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19390,552,0.99 [0.92-1.08],0.8872566112306295
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19271,137,0.96 [0.82-1.12],0.5669115007799439
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17722,2764,1.01 [0.98-1.05],0.5766708616319602
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19634,295,0.97 [0.87-1.08],0.6004320518090371
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19785,159,1.05 [0.91-1.21],0.5087012264502806
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19153,462,0.96 [0.88-1.05],0.3918748678687949
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19418,79,1.04 [0.84-1.27],0.7397136783527231
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19788,59,1.26 [1.00-1.60],0.0525240566551529
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,18801,110,0.84 [0.71-1.01],0.0599933359572984
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18845,154,0.80 [0.68-0.92],0.0028372899265709
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18502,141,1.13 [0.96-1.31],0.1319803074185917
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,18991,46,1.02 [0.77-1.33],0.9065982200211038
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18425,64,0.85 [0.68-1.08],0.1788643583650611
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,18938,100,0.94 [0.78-1.13],0.5268139312099038
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19083,245,1.03 [0.92-1.16],0.629602844039898
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,18820,129,1.05 [0.89-1.23],0.5837198308651355
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18440,79,1.21 [0.99-1.49],0.063290961955616
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18465,104,1.09 [0.91-1.31],0.3466432624956749
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17265,2307,0.99 [0.95-1.03],0.504817986009324
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,18772,81,1.13 [0.92-1.38],0.2607452656168672
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19558,424,1.00 [0.91-1.09],0.9942379820864382
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19201,67,1.00 [0.80-1.25],0.9724256896968132
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19299,165,1.03 [0.89-1.19],0.7059403320619417
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19599,96,0.91 [0.75-1.10],0.3248706300618277
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19767,116,1.07 [0.90-1.27],0.4184686618001005
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19691,95,1.14 [0.94-1.37],0.1788589286282081
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19563,60,1.04 [0.82-1.32],0.7445376483325115
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,19563,60,1.04 [0.82-1.31],0.7761084686024631
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19707,1014,1.02 [0.96-1.08],0.4589111689187696
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19462,769,1.03 [0.97-1.10],0.3535609636654062
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,18820,127,0.89 [0.75-1.05],0.1633159143024634
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,18769,76,1.15 [0.93-1.41],0.1989314403972618
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,19633,52,0.92 [0.71-1.19],0.5146093937538094
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19734,153,0.93 [0.80-1.08],0.3221606862086665
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19631,50,0.85 [0.66-1.10],0.221868675920625
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,All influenza,17576,129,1.07 [0.91-1.25],0.4370627017641824
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17573,126,1.09 [0.93-1.28],0.2959104384838202
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12278,83,1.16 [0.95-1.42],0.1381899338590956
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,19718,202,1.04 [0.91-1.18],0.5913057348077784
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13359,1482,1.03 [0.98-1.08],0.2580101474853414
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13659,1464,1.02 [0.98-1.07],0.3413366238128579
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19361,152,1.07 [0.93-1.25],0.3483530341582237
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17534,87,1.09 [0.89-1.32],0.4018066651546744
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Bronchiectasis,16579,434,1.06 [0.97-1.16],0.1924433330705912
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",16206,61,1.13 [0.90-1.43],0.2947577598607221
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,18837,2692,1.01 [0.98-1.05],0.4759396278707865
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18751,67,0.96 [0.77-1.20],0.7350101897796925
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,18799,115,0.97 [0.81-1.15],0.6895845496358954
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19552,1373,0.98 [0.94-1.03],0.5382893836039181
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,18755,71,0.94 [0.75-1.16],0.547006417403699
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17956,5156,1.01 [0.98-1.04],0.4486437678300204
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18980,296,1.02 [0.92-1.14],0.6664853410247511
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Early onset COPD,18281,102,0.94 [0.78-1.12],0.4756913438310665
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Emphysema,16517,372,0.98 [0.89-1.08],0.6496268856382564
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18669,405,1.00 [0.91-1.09],0.9792845530848278
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19577,2130,1.00 [0.96-1.04],0.8862818874511178
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,18704,440,1.02 [0.94-1.12],0.5991122450537765
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Later onset COPD,19341,1271,0.99 [0.94-1.04],0.660699397336771
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19785,382,0.97 [0.88-1.06],0.4842580830873324
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Nasal polyp,18769,85,0.91 [0.74-1.11],0.352744894501779
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19560,1065,1.00 [0.94-1.06],0.9388745355846708
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,19555,2269,0.99 [0.96-1.03],0.7390807927331755
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19331,647,1.02 [0.95-1.10],0.5876697784282218
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other pleural conditions,17340,54,0.77 [0.60-0.99],0.0397320511732236
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19687,518,1.02 [0.94-1.11],0.5588970677780474
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19688,1451,1.03 [0.98-1.08],0.3148632230081313
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pleural effusion,18416,1130,0.97 [0.92-1.02],0.2589092221925924
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pleural plaque,17511,225,0.98 [0.87-1.11],0.7965057407725641
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19336,1889,1.00 [0.96-1.05],0.8766976255557581
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19688,285,0.98 [0.88-1.09],0.7102596337831729
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pneumothorax,17437,151,0.83 [0.72-0.97],0.016663647270248
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pollen allergy,19792,170,1.09 [0.95-1.26],0.2077267138923355
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,19245,76,0.85 [0.69-1.06],0.1435220991918428
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12255,60,1.25 [0.99-1.57],0.0617768103465275
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19544,1049,1.00 [0.94-1.06],0.9443227320351631
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18887,203,1.04 [0.92-1.18],0.528410428847683
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Viral pneumonia,17692,245,1.03 [0.92-1.16],0.6255218066871386
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19372,196,0.97 [0.85-1.10],0.6198972182431951
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6387,103,1.06 [0.88-1.27],0.532138318492765
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12658,49,1.03 [0.79-1.34],0.8327651399699165
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute appendicitis,19698,109,1.02 [0.86-1.22],0.7988728640853013
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute gastritis,13852,83,1.06 [0.87-1.30],0.5649600140664568
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,18093,167,0.99 [0.86-1.15],0.9406908151784444
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Acute peritonitis,19392,93,1.07 [0.89-1.30],0.4584254693991759
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,18973,50,0.70 [0.54-0.91],0.0080671468903134
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,14188,419,0.98 [0.89-1.07],0.625849269926573
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",18045,119,1.13 [0.95-1.33],0.1655429848754008
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19446,119,1.12 [0.95-1.33],0.1740114253890181
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Cholecystitis,18109,183,0.93 [0.81-1.07],0.3161535561591661
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Cholelithiasis,18814,888,1.01 [0.95-1.08],0.7059905608868651
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Chronic gastritis,14067,298,1.00 [0.90-1.11],0.9841813755321804
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,17973,47,0.76 [0.58-1.00],0.0504941867596303
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19682,105,0.78 [0.64-0.93],0.0068575574726148
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Coeliac disease,18341,100,1.10 [0.92-1.32],0.3146616071891076
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Collagenous colitis,18313,85,0.86 [0.70-1.05],0.1342282937368162
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19702,143,1.04 [0.89-1.21],0.650438031261295
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Constipation,19562,1753,0.99 [0.95-1.03],0.6625791095095659
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Crohn disease,18298,70,0.89 [0.71-1.11],0.2959406546675284
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19502,55,0.85 [0.66-1.09],0.2018445797585572
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18292,64,1.00 [0.80-1.26],0.97251026270132
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Dental caries,19270,159,0.94 [0.81-1.08],0.380134960350333
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,17164,2156,0.99 [0.95-1.03],0.7406494442893548
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of appendix,19724,135,1.01 [0.86-1.19],0.8839728557528458
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of liver,19703,780,0.93 [0.87-0.99],0.0312531830528118
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17651,3882,0.99 [0.96-1.02],0.571730776103839
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19513,402,0.96 [0.88-1.06],0.4174637210895451
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19727,428,1.00 [0.92-1.10],0.957768453722602
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19189,78,0.97 [0.79-1.19],0.7645243632754072
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19083,45,0.93 [0.71-1.23],0.6236013084397054
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19532,1291,0.96 [0.91-1.01],0.1172732568239229
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diseases of tongue,19092,79,1.06 [0.87-1.31],0.5557375333873819
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19212,1286,1.01 [0.96-1.06],0.7476533239802683
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15833,3224,0.98 [0.94-1.01],0.1401807235604179
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,13973,204,0.99 [0.87-1.13],0.8856832620751374
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19713,164,1.01 [0.87-1.16],0.9267842196119216
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19774,19,1.15 [0.75-1.75],0.5287501440305452
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19047,124,0.82 [0.69-0.97],0.0180602047405067
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12704,95,1.18 [0.98-1.43],0.0820415230155002
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,14255,486,1.03 [0.95-1.12],0.450324692603971
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastric ulcer,14127,358,0.99 [0.90-1.09],0.8779311924721571
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16015,2246,0.98 [0.94-1.02],0.3719706501576344
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14313,544,0.99 [0.92-1.08],0.8885018745194424
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14390,7005,0.99 [0.97-1.01],0.2465922316436667
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,GI-bleeding,19307,1066,0.95 [0.90-1.01],0.080899116955268
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19156,45,0.83 [0.62-1.09],0.1842235387099424
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13449,1002,0.96 [0.90-1.02],0.1466514534060396
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",18981,58,0.74 [0.58-0.95],0.0169783231398846
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Hernia,18069,3061,1.00 [0.97-1.03],0.9055100653807898
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Impacted teeth,19776,18,1.18 [0.77-1.82],0.4503494897882595
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Impaction of intestines,12675,66,0.89 [0.71-1.12],0.304116137190268
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Inguinal hernia,15928,920,0.98 [0.93-1.05],0.607562462788077
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15108,100,0.98 [0.81-1.17],0.7960749330150831
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12705,96,0.87 [0.72-1.06],0.1646293164664578
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18360,119,1.05 [0.89-1.24],0.5705871802020969
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,13038,429,0.96 [0.88-1.05],0.4238895193115021
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19779,280,1.00 [0.89-1.12],0.9997651246272914
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18890,662,1.01 [0.94-1.09],0.7796806327758192
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19153,925,0.97 [0.91-1.03],0.3067694050929929
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,13954,185,0.83 [0.72-0.95],0.0064061614268648
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oesophagitis,14369,600,1.00 [0.92-1.07],0.9119005895113272
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19751,116,1.04 [0.88-1.23],0.647031913359705
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15077,69,0.96 [0.77-1.20],0.7194352050642879
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13771,1162,1.00 [0.95-1.06],0.995882866784398
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18223,297,1.00 [0.90-1.12],0.9383817326411892
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,18050,124,1.03 [0.87-1.21],0.7345017440346742
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,14246,1637,0.99 [0.94-1.03],0.5284198722637963
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,17840,5231,0.97 [0.95-1.00],0.0405721158508264
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19065,182,1.04 [0.91-1.20],0.5319461384706231
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of liver,19568,645,0.93 [0.86-1.00],0.0482997092784951
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14412,643,0.96 [0.90-1.04],0.3247716831663541
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,18103,177,0.92 [0.80-1.06],0.2582540636676809
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19662,363,0.98 [0.89-1.08],0.7509069376720777
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14697,928,0.97 [0.91-1.03],0.3259032885293295
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19319,1078,0.95 [0.90-1.00],0.0725323663526779
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19258,147,0.98 [0.84-1.14],0.817229606610699
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14398,1789,0.98 [0.94-1.02],0.3764301174523843
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15617,1848,0.97 [0.92-1.01],0.1057163779471775
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19020,97,0.91 [0.75-1.09],0.3067667508348086
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19045,817,0.97 [0.91-1.04],0.4254648576411907
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12984,375,0.92 [0.84-1.01],0.0855400750976363
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19771,23,1.26 [0.86-1.85],0.2332311999225638
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,13130,521,0.92 [0.85-1.00],0.0408310984807143
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18381,140,0.91 [0.78-1.06],0.2265255074765047
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,19789,44,0.77 [0.58-1.02],0.0696945162710776
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19106,86,0.95 [0.78-1.16],0.6429891057717214
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Toxic colitis,18300,72,0.90 [0.72-1.12],0.3508359365330652
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,14065,296,0.97 [0.87-1.08],0.5984341298191045
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,18370,142,0.93 [0.80-1.09],0.3782810642305788
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18343,115,0.92 [0.78-1.09],0.3536495897288553
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Umbilical hernia,15225,217,0.95 [0.84-1.08],0.4151514769084343
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,12814,205,0.87 [0.76-0.99],0.0313046044402721
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Ventral hernia,15241,233,1.02 [0.90-1.15],0.7696153250960205
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XI Diseases of the digestive system,Volvulus,12684,75,0.86 [0.70-1.07],0.1757428233735881
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19714,350,1.04 [0.94-1.14],0.4842439926353198
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19495,62,1.08 [0.86-1.37],0.5144245681453407
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17670,142,1.01 [0.86-1.17],0.942661966473614
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19268,701,0.99 [0.92-1.06],0.7269683813167342
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18688,121,1.02 [0.87-1.21],0.7735463700498233
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,18032,504,0.93 [0.86-1.01],0.0978071932827683
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19504,264,0.98 [0.88-1.10],0.7745377895431842
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19705,465,0.97 [0.89-1.05],0.4235127566015544
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19285,45,0.92 [0.70-1.21],0.5521909037885415
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18443,3155,0.98 [0.95-1.02],0.3441113091915387
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19431,371,1.01 [0.92-1.12],0.7786545208689534
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19315,255,1.06 [0.94-1.19],0.3231237530952526
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19475,908,0.98 [0.93-1.05],0.6229971777409485
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19784,49,1.06 [0.81-1.37],0.6840659272078113
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17584,56,0.97 [0.76-1.24],0.8050280335226361
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19115,55,0.94 [0.73-1.21],0.6304817668930385
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19492,252,0.98 [0.87-1.10],0.7578101506768282
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18034,506,0.98 [0.91-1.07],0.6926270434723749
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17606,78,0.85 [0.69-1.05],0.1304987344930702
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19728,73,0.86 [0.69-1.07],0.1664236777686951
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18750,183,1.07 [0.93-1.23],0.3438888102239408
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19626,193,0.97 [0.85-1.10],0.6185858183684778
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19315,75,0.91 [0.74-1.13],0.4083902898671059
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17590,62,0.95 [0.75-1.20],0.6641894335252154
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19283,1755,0.97 [0.93-1.02],0.2170796593330666
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18072,544,0.97 [0.90-1.05],0.460334489186683
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17609,81,0.84 [0.68-1.03],0.0855688107644343
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19723,290,1.04 [0.94-1.16],0.4590339765176351
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19306,66,1.04 [0.83-1.30],0.7471963595347123
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19673,240,1.03 [0.91-1.16],0.6275146718607516
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19743,379,1.03 [0.94-1.13],0.5035708129620768
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17633,105,1.02 [0.86-1.22],0.7981239656446203
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17810,282,0.94 [0.84-1.05],0.2799065684741534
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19731,367,1.02 [0.93-1.13],0.639812203766886
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",17795,267,1.04 [0.93-1.17],0.4835196895341754
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19777,122,0.93 [0.79-1.10],0.4251872812462733
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16532,66,0.95 [0.75-1.19],0.6302178838557951
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17472,5460,1.01 [0.99-1.04],0.3756275217286976
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16280,4268,1.02 [0.99-1.05],0.214828280455233
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16510,44,1.02 [0.77-1.34],0.9025715809430126
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16500,118,0.98 [0.83-1.16],0.8077953220470246
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16542,160,0.95 [0.82-1.10],0.4807876103555787
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19583,52,0.80 [0.62-1.04],0.0938689601994452
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16509,127,0.96 [0.82-1.13],0.6385144571331969
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13280,1268,1.03 [0.98-1.08],0.2716217602979104
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19613,211,1.02 [0.90-1.16],0.7381675348123626
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16857,475,1.04 [0.95-1.13],0.383848027961557
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16043,6832,1.01 [0.99-1.03],0.4856749189382363
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17666,103,0.97 [0.81-1.16],0.7514292376575723
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16619,153,1.01 [0.87-1.17],0.907845325884672
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16903,437,1.03 [0.94-1.12],0.5369639726902282
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18993,2611,1.00 [0.96-1.04],0.994613041975149
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16735,269,0.89 [0.80-1.00],0.0510389431252772
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16590,124,1.17 [0.99-1.38],0.0610330506499911
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16568,102,1.03 [0.86-1.24],0.7139157781658687
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19135,88,0.94 [0.78-1.15],0.5667818427549274
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13710,1698,1.01 [0.96-1.05],0.7876955762115072
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12655,643,1.04 [0.96-1.11],0.3537353568948507
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19715,637,1.03 [0.96-1.11],0.3807051901545626
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,12075,63,1.03 [0.82-1.29],0.8183042275473063
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12277,265,0.94 [0.84-1.05],0.2828355570431553
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16689,223,0.96 [0.85-1.09],0.5227650153738375
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12417,405,1.07 [0.98-1.18],0.1277472191570555
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16449,67,1.35 [1.09-1.69],0.0071021363644131
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16943,561,1.01 [0.94-1.09],0.7596372348466721
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16634,252,1.00 [0.89-1.12],0.9880497047931605
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12391,379,1.07 [0.97-1.18],0.1600479618437985
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16526,60,1.12 [0.88-1.42],0.352358120740552
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16513,47,1.17 [0.90-1.53],0.2371329967893654
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17631,68,1.03 [0.82-1.29],0.7850180964331128
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19436,1873,0.94 [0.90-0.98],0.0063915871004239
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,18885,1322,0.94 [0.89-0.99],0.0113146409220139
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19665,462,1.05 [0.97-1.15],0.224518578231025
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14676,2664,1.02 [0.98-1.06],0.270643733290417
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,12051,39,0.85 [0.63-1.15],0.3009868703882186
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16552,86,1.18 [0.97-1.44],0.0920532314747137
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,12074,62,0.94 [0.74-1.19],0.6261626184275111
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),12129,117,1.02 [0.86-1.21],0.7972837233489662
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17767,204,0.88 [0.78-1.01],0.0641358698855679
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,17974,411,0.92 [0.84-1.01],0.0649074293004664
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19784,91,1.14 [0.94-1.38],0.1807131036817765
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",18030,1648,1.00 [0.96-1.05],0.9235619668873548
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16525,59,1.45 [1.15-1.83],0.0018000607638914
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),12138,126,0.96 [0.82-1.13],0.6469987537352148
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,17039,657,1.02 [0.95-1.10],0.5295784674353341
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,13858,1846,1.02 [0.98-1.07],0.3166486495212589
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19156,109,1.00 [0.84-1.20],0.9639584782128582
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19794,59,1.09 [0.86-1.38],0.4928103761231455
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16535,69,1.11 [0.89-1.38],0.3647865909332458
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17589,1123,1.07 [1.01-1.13],0.0154482378904254
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16555,89,0.99 [0.81-1.20],0.8856416167528375
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13769,1757,1.03 [0.98-1.07],0.2254496751738787
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17664,101,0.90 [0.75-1.08],0.2609994983186062
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16494,28,1.05 [0.74-1.49],0.7770434144187365
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16547,165,0.90 [0.78-1.04],0.1514490706255373
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17030,564,1.03 [0.95-1.11],0.500146800230445
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19472,425,1.09 [0.99-1.19],0.0688949447759001
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16923,541,0.99 [0.91-1.07],0.7418416007041924
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19676,457,1.04 [0.96-1.14],0.3303184545480792
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19780,55,1.29 [1.01-1.64],0.0400023288305435
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16605,139,0.93 [0.80-1.09],0.391992746414711
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15434,729,1.04 [0.97-1.11],0.3157966406655876
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16999,533,1.06 [0.98-1.14],0.1791510347943181
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16708,242,0.89 [0.79-1.01],0.0626420068249416
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",12075,63,1.04 [0.82-1.31],0.7677703361786402
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14649,2637,1.03 [0.99-1.06],0.1730597564427659
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12714,702,1.03 [0.96-1.10],0.3992402485789466
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19361,314,1.06 [0.96-1.18],0.2365560197165316
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19755,62,1.03 [0.81-1.30],0.8024188785878382
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17559,59,1.32 [1.04-1.68],0.0241680123234814
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,12072,60,1.08 [0.85-1.37],0.5217501567510292
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16471,89,1.05 [0.86-1.27],0.6292493969996464
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12481,469,1.06 [0.98-1.16],0.1492108619810169
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16753,287,1.04 [0.93-1.16],0.5085276185452687
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16621,239,1.09 [0.97-1.23],0.1589848789563983
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16600,218,1.02 [0.90-1.16],0.7022734806706094
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,13967,60,1.18 [0.94-1.50],0.1563236724994874
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19784,59,1.23 [0.97-1.56],0.0811367754670247
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16933,467,1.05 [0.96-1.14],0.3061878093813266
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],19136,89,1.20 [0.99-1.45],0.0639944400208866
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18685,2219,1.04 [1.00-1.08],0.0794542441776726
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16591,125,0.98 [0.83-1.16],0.8045086724442786
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16950,568,0.99 [0.92-1.07],0.8430115216102827
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18610,225,0.90 [0.80-1.02],0.1006943106793049
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16582,200,0.99 [0.87-1.13],0.8520763997865759
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,18025,1643,0.99 [0.94-1.03],0.625455324566105
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17457,1075,1.01 [0.95-1.07],0.7585034791139988
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16514,48,1.11 [0.85-1.45],0.4408211740383559
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19157,110,0.95 [0.80-1.13],0.536734052974595
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16609,143,1.08 [0.92-1.26],0.3412769503650338
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16546,80,0.92 [0.75-1.14],0.4552584045683587
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),12074,62,1.13 [0.89-1.42],0.317302187277676
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,18669,1814,0.98 [0.94-1.02],0.3306132759232215
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7996,22,1.41 [0.96-2.07],0.0835970740115702
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,10140,28,1.36 [0.97-1.92],0.0786104013928114
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19529,262,1.01 [0.91-1.14],0.8062512323102367
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19354,87,0.97 [0.79-1.18],0.760603047672415
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18591,1736,0.95 [0.91-0.99],0.0241809817761894
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19619,86,0.84 [0.68-1.03],0.0853169354232666
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19574,330,0.94 [0.85-1.04],0.2510167945888684
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Cystitis,16615,256,0.98 [0.87-1.10],0.6956743725605816
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Dialysis,16924,69,1.16 [0.93-1.45],0.1957791454322266
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8657,1792,1.02 [0.98-1.07],0.336884262117713
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10222,110,1.11 [0.93-1.33],0.2375506998450422
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,8008,34,1.26 [0.92-1.73],0.1424230818109566
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8465,491,1.04 [0.95-1.12],0.405213745476095
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16363,5250,0.99 [0.97-1.02],0.4506852174114337
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19600,67,1.06 [0.85-1.33],0.6020648271019355
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,6969,104,1.00 [0.84-1.20],0.98560326821231
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,16888,277,1.01 [0.90-1.13],0.8873268695576946
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8392,1527,1.01 [0.96-1.06],0.7348563482477557
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10283,139,1.02 [0.87-1.19],0.8110303321850465
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6969,104,0.87 [0.73-1.05],0.1446295393686116
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16431,72,1.02 [0.82-1.26],0.8860098037478392
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8851,877,0.97 [0.92-1.04],0.4070657907352647
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,6914,49,0.89 [0.68-1.15],0.3682959636092879
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,8007,33,0.82 [0.59-1.13],0.2328518500323083
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19795,73,0.96 [0.77-1.19],0.7064556061018533
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19790,73,0.84 [0.67-1.04],0.1055778288483475
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18790,2431,0.96 [0.93-1.00],0.0337671237657641
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,17153,794,0.94 [0.88-1.00],0.0443915064224051
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,10158,46,1.08 [0.82-1.41],0.5936778362143282
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19738,494,0.97 [0.89-1.05],0.431285207519033
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6986,121,1.06 [0.90-1.25],0.5013741728625862
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6996,131,1.00 [0.85-1.17],0.9726077682932928
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,6993,128,1.03 [0.88-1.21],0.7065684939902583
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19771,71,1.00 [0.80-1.24],0.974298167699946
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18266,1907,0.98 [0.94-1.02],0.2738811069406759
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10215,71,0.99 [0.80-1.24],0.9515366990990304
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,8036,62,1.13 [0.90-1.43],0.2908012199348385
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8104,130,0.95 [0.81-1.12],0.5402207436114284
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,8024,50,0.86 [0.66-1.12],0.2565338783204953
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,8060,86,0.93 [0.76-1.13],0.45934799638874
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16936,325,1.02 [0.92-1.13],0.7060975100643408
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19403,159,0.98 [0.84-1.13],0.7615973089526799
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,8077,103,0.99 [0.83-1.19],0.9486542613556026
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7996,22,0.71 [0.48-1.06],0.0947085456099696
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8157,183,0.92 [0.80-1.05],0.2075273799261671
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,8056,82,1.21 [0.99-1.47],0.0661684283503716
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8155,181,0.88 [0.76-1.01],0.0646582779765556
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19580,47,0.87 [0.66-1.14],0.3022411800527366
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6992,127,0.90 [0.76-1.06],0.2087726364240417
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19594,2983,0.98 [0.94-1.01],0.1471870788056998
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",16685,74,1.05 [0.85-1.30],0.6489902762302164
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16994,139,1.01 [0.86-1.18],0.8960611532436498
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19300,33,1.13 [0.82-1.56],0.4531368054823806
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16586,227,0.97 [0.86-1.10],0.6736374799112494
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19603,336,1.01 [0.92-1.12],0.8121777826139446
TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,8006,32,0.92 [0.66-1.28],0.6113127274094852
